These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37952132)

  • 1. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
    Healey JS; Lopes RD; Granger CB; Alings M; Rivard L; McIntyre WF; Atar D; Birnie DH; Boriani G; Camm AJ; Conen D; Erath JW; Gold MR; Hohnloser SH; Ip J; Kautzner J; Kutyifa V; Linde C; Mabo P; Mairesse G; Benezet Mazuecos J; Cosedis Nielsen J; Philippon F; Proietti M; Sticherling C; Wong JA; Wright DJ; Zarraga IG; Coutts SB; Kaplan A; Pombo M; Ayala-Paredes F; Xu L; Simek K; Nevills S; Mian R; Connolly SJ;
    N Engl J Med; 2024 Jan; 390(2):107-117. PubMed ID: 37952132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apixaban vs Aspirin According to CHA
    Lopes RD; Granger CB; Wojdyla DM; McIntyre WF; Alings M; Mani T; Ramasundarahettige C; Rivard L; Atar D; Birnie DH; Boriani G; Amit G; Leong-Sit P; Rinne C; Duray GZ; Gold MR; Hohnloser SH; Kutyifa V; Benezet-Mazuecos J; Cosedis Nielsen J; Sticherling C; Benz AP; Linde C; Kautzner J; Mabo P; Mairesse GH; Connolly SJ; Healey JS
    J Am Coll Cardiol; 2024 Jul; 84(4):354-364. PubMed ID: 39019530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apixaban in patients with atrial fibrillation.
    Connolly SJ; Eikelboom J; Joyner C; Diener HC; Hart R; Golitsyn S; Flaker G; Avezum A; Hohnloser SH; Diaz R; Talajic M; Zhu J; Pais P; Budaj A; Parkhomenko A; Jansky P; Commerford P; Tan RS; Sim KH; Lewis BS; Van Mieghem W; Lip GY; Kim JH; Lanas-Zanetti F; Gonzalez-Hermosillo A; Dans AL; Munawar M; O'Donnell M; Lawrence J; Lewis G; Afzal R; Yusuf S;
    N Engl J Med; 2011 Mar; 364(9):806-17. PubMed ID: 21309657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
    Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
    Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban versus warfarin in patients with atrial fibrillation.
    Granger CB; Alexander JH; McMurray JJ; Lopes RD; Hylek EM; Hanna M; Al-Khalidi HR; Ansell J; Atar D; Avezum A; Bahit MC; Diaz R; Easton JD; Ezekowitz JA; Flaker G; Garcia D; Geraldes M; Gersh BJ; Golitsyn S; Goto S; Hermosillo AG; Hohnloser SH; Horowitz J; Mohan P; Jansky P; Lewis BS; Lopez-Sendon JL; Pais P; Parkhomenko A; Verheugt FW; Zhu J; Wallentin L;
    N Engl J Med; 2011 Sep; 365(11):981-92. PubMed ID: 21870978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial.
    Hu PT; Lopes RD; Stevens SR; Wallentin L; Thomas L; Alexander JH; Hanna M; Lewis BS; Verheugt FW; Granger CB; Jones WS
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial.
    Ng KH; Shestakovska O; Connolly SJ; Eikelboom JW; Avezum A; Diaz R; Lanas F; Yusuf S; Hart RG
    Age Ageing; 2016 Jan; 45(1):77-83. PubMed ID: 26590293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.
    Ray WA; Chung CP; Stein CM; Smalley W; Zimmerman E; Dupont WD; Hung AM; Daugherty JR; Dickson A; Murray KT
    JAMA; 2021 Dec; 326(23):2395-2404. PubMed ID: 34932078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
    Kirchhof P; Toennis T; Goette A; Camm AJ; Diener HC; Becher N; Bertaglia E; Blomstrom Lundqvist C; Borlich M; Brandes A; Cabanelas N; Calvert M; Chlouverakis G; Dan GA; de Groot JR; Dichtl W; Kravchuk B; Lubiński A; Marijon E; Merkely B; Mont L; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Sznajder R; Velchev V; Wichterle D; Sehner S; Simantirakis E; Lip GYH; Vardas P; Schotten U; Zapf A; ;
    N Engl J Med; 2023 Sep; 389(13):1167-1179. PubMed ID: 37622677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
    Piccini JP; Caso V; Connolly SJ; Fox KAA; Oldgren J; Jones WS; Gorog DA; Durdil V; Viethen T; Neumann C; Mundl H; Patel MR;
    Lancet; 2022 Apr; 399(10333):1383-1390. PubMed ID: 35385695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
    Kamel H; Longstreth WT; Tirschwell DL; Kronmal RA; Marshall RS; Broderick JP; Aragón García R; Plummer P; Sabagha N; Pauls Q; Cassarly C; Dillon CR; Di Tullio MR; Hod EA; Soliman EZ; Gladstone DJ; Healey JS; Sharma M; Chaturvedi S; Janis LS; Krishnaiah B; Nahab F; Kasner SE; Stanton RJ; Kleindorfer DO; Starr M; Winder TR; Clark WM; Miller BR; Elkind MSV;
    JAMA; 2024 Feb; 331(7):573-581. PubMed ID: 38324415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
    Lopes RD; Al-Khatib SM; Wallentin L; Yang H; Ansell J; Bahit MC; De Caterina R; Dorian P; Easton JD; Erol C; Ezekowitz JA; Gersh BJ; Granger CB; Hohnloser SH; Horowitz J; Hylek EM; McMurray JJ; Mohan P; Vinereanu D; Alexander JH
    Lancet; 2012 Nov; 380(9855):1749-58. PubMed ID: 23036896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia.
    Hersi AS; Osenenko KM; Kherraf SA; Aziz AA; Sambrook RJ
    Ann Saudi Med; 2019; 39(4):265-278. PubMed ID: 31381381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
    Lip GY; Lanitis T; Mardekian J; Kongnakorn T; Phatak H; Dorian P
    Stroke; 2015 Oct; 46(10):2830-7. PubMed ID: 26316345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
    Lopes RD; Heizer G; Aronson R; Vora AN; Massaro T; Mehran R; Goodman SG; Windecker S; Darius H; Li J; Averkov O; Bahit MC; Berwanger O; Budaj A; Hijazi Z; Parkhomenko A; Sinnaeve P; Storey RF; Thiele H; Vinereanu D; Granger CB; Alexander JH;
    N Engl J Med; 2019 Apr; 380(16):1509-1524. PubMed ID: 30883055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES.
    Benz AP; Eikelboom JW; Yusuf S; Hohnloser SH; Kahl A; Beresh H; Balasubramanian K; Healey JS; Connolly SJ
    Thromb Haemost; 2021 Apr; 121(4):518-528. PubMed ID: 33011964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Alexander JH; Lopes RD; Thomas L; Alings M; Atar D; Aylward P; Goto S; Hanna M; Huber K; Husted S; Lewis BS; McMurray JJ; Pais P; Pouleur H; Steg PG; Verheugt FW; Wojdyla DM; Granger CB; Wallentin L
    Eur Heart J; 2014 Jan; 35(4):224-32. PubMed ID: 24144788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.